Free Trial

Deutsche Bank AG Purchases 71,444 Shares of CME Group Inc. (NASDAQ:CME)

CME Group logo with Finance background

Key Points

  • Deutsche Bank AG increased its holdings in CME Group by 5.3%, purchasing an additional 71,444 shares, bringing its total to 1,413,361 shares worth approximately $374.95 million.
  • CME Group's latest quarterly earnings report showed earnings per share of $2.96, exceeding estimates, with revenue up 10.4% year-over-year at $1.69 billion.
  • The company announced a quarterly dividend of $1.25, translating to a 1.8% dividend yield, with a payout ratio of 48.40%.
  • Need Better Tools to Track CME Group? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Deutsche Bank AG lifted its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 5.3% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,413,361 shares of the financial services provider's stock after purchasing an additional 71,444 shares during the quarter. Deutsche Bank AG owned 0.39% of CME Group worth $374,951,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Vanguard Group Inc. grew its stake in shares of CME Group by 1.2% in the 1st quarter. Vanguard Group Inc. now owns 34,643,827 shares of the financial services provider's stock worth $9,190,661,000 after buying an additional 400,737 shares in the last quarter. Price T Rowe Associates Inc. MD raised its position in shares of CME Group by 89.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock valued at $1,923,047,000 after buying an additional 3,921,278 shares in the last quarter. Northern Trust Corp lifted its holdings in shares of CME Group by 11.4% in the 4th quarter. Northern Trust Corp now owns 3,943,454 shares of the financial services provider's stock valued at $915,788,000 after acquiring an additional 403,920 shares during the last quarter. Janus Henderson Group PLC lifted its holdings in shares of CME Group by 24.7% in the 4th quarter. Janus Henderson Group PLC now owns 3,135,753 shares of the financial services provider's stock valued at $728,260,000 after acquiring an additional 621,713 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA grew its position in CME Group by 29.9% in the first quarter. Massachusetts Financial Services Co. MA now owns 2,818,590 shares of the financial services provider's stock worth $747,744,000 after acquiring an additional 648,591 shares in the last quarter. Institutional investors own 87.75% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on CME shares. Citigroup upped their price objective on CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research report on Thursday, July 3rd. Morgan Stanley boosted their target price on CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a research report on Thursday, April 24th. JPMorgan Chase & Co. decreased their price target on CME Group from $223.00 to $211.00 and set an "underweight" rating on the stock in a report on Thursday, April 24th. Wall Street Zen lowered shares of CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Finally, Barclays set a $298.00 price objective on shares of CME Group and gave the company an "equal weight" rating in a research report on Thursday, July 24th. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $261.93.

View Our Latest Analysis on CME Group

CME Group Price Performance

CME Group stock opened at $280.95 on Friday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a market cap of $101.25 billion, a price-to-earnings ratio of 27.20, a price-to-earnings-growth ratio of 5.00 and a beta of 0.44. The firm has a 50-day moving average of $275.95 and a two-hundred day moving average of $265.32. CME Group Inc. has a 1 year low of $202.35 and a 1 year high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The firm had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter in the previous year, the firm posted $2.56 earnings per share. The company's revenue was up 10.4% on a year-over-year basis. On average, research analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be issued a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. CME Group's dividend payout ratio is 48.40%.

Insider Buying and Selling at CME Group

In other news, Director Martin J. Gepsman sold 300 shares of the firm's stock in a transaction on Thursday, May 15th. The stock was sold at an average price of $273.17, for a total transaction of $81,951.00. Following the transaction, the director owned 24,767 shares in the company, valued at approximately $6,765,601.39. This trade represents a 1.20% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Charles P. Carey sold 3,000 shares of the company's stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $272.56, for a total transaction of $817,680.00. Following the completion of the sale, the director directly owned 5,400 shares of the company's stock, valued at approximately $1,471,824. This trade represents a 35.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 5,750 shares of company stock worth $1,576,294. Insiders own 0.30% of the company's stock.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines